Артропатия Шарко: место встречи ревматолога и эндокринолога

1. <div><p>Sanders L.J., Frykberg R.G. Diabetic neuropathic osteoarthropathy: Charcot foot. In: The high risk foot in Diabetes Mellitus. Ed. by Frykberg R.G. New York: Churchill Livingstone, 1991.</p><p>Levin M.E., O'Neal L.W., Bowker J.H. Eds New York: Churchill Livingstone, 1991:297-338.</p><p>Sanders L.J., Frykberg R.G. Charcot foot. In: Levin M.E., O'Neal L.W., Bowker J.H. eds. The Diabetic Foot. St. Louis: Mosby, 1993:149-80.</p><p>Rajbhandari S.M., Jenkins R.C., Davies C. et al. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002;45:1085-96.</p><p>Armstrong D.G., Todd W.F., Lavery L.A. et al. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabetic Med 1997;14:357-63.</p><p>Brower A.C., Allman R.M. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology 1981;139:349-54.</p><p>Lavery L.A., Armstrong D.G., Walker S.C. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot's arthropathy. Diabetic Med 1997;14:46-9.</p><p>Fabrin J., Larsen K., Holstein P.E. Longterm follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 2000;23:796-800.</p><p>Armstrong D.G., Lavery L.A. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am 1998;80A:365-9.</p><p>Young M.J., Marshall A., Adams J.E. et al. neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-8.</p><p>Chantelau E., Onvlee G.J. Charcot Foot in Diabetes. Horm Metab Res 2006;38:361-367.</p><p>Yu G.V., Hudson J.R. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc 2002;92:210-20.</p><p>Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy - is RANK-L the missing link? Diabetologia 2004;47:1488-92.</p><p>Hofbauer L.C., Schoppet M. Clinical implications of the osteoprotegerin RANKL/RANK for bone and vascular diseases. JAMA 2004;292:490-5.</p><p>Mabilleau G., Petrova N.L., Edmonds M.E. et al. Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 2008;51:1035-40.</p><p>Sommer T.C., Lee T.H. Charcot Foot: The Diagnostic Dilemma. Am Fam Physician 2001;64:1591-8.</p><p>Eichenholtz S.N. Charcot joints. Springfield:Thomas, 1966.</p><p>Sella E.J., Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999;38:34-40.</p><p>Kirsch T. Determinants of pathological mineralization. Current Opinion in Rheumatol 2006;18:174-80.</p><p>Zaka R., Williams C.J. Role of progressive ankylosis gene in cartilage mineralization. Current Opinion in Rheumatol 2006;18:181-6.</p><p>Graff R.D., Picher M., Lee G.M. Extracellular nucleotides, cartilage stress, and calcium crystal formation. Current Opinion in Rheumatol 2003;15:315-20.</p><p>Announ N., Guerne P.A. Calcium pyrophosphate dihydrate crystal induced arthropathy. Rev Med Suisse 2007 Mar 21;3(103):740-6.</p><p>Brodsky J.W. Outpatient diagnosis and care of the diabetic foot. Instr Course Lect 1993;42:121-39.</p><p>Brodsky J.W. The diabetic foot. In: Mann R.A., Coughlin M.J., eds. Surgery of the foot and ankle. 6th ed. St. Louis: Mosby, 1993.</p><p>Jude E.B., Boulton A.J. Medical treatment of Charcot's arthropathy. J Am Podiatr Med Assoc 2002;92:381-3.</p><p>Pitocco D., Ruotolo V., Caputo S. et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy. Diabetes Care 2005;28(5):1214-5.</p><p>Bem R., Jircovsca A., Fejfarova V. et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy. Diabetes Care 2006;29(6):1392-4.</p></div><br />